Sanofi R&D director John Reed and Innovent CEO Michael Yu
Sanofi fronts €300M to partner up with Innovent on China market, eyeing quick pivot to commercialization
Sanofi has found a high-profile partner in China to take two of its top cancer drug prospects through the clinic and onto the big Asian …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
